L
7.57
0.14 (1.88%)
| Previous Close | 7.43 |
| Open | 7.46 |
| Volume | 37,596,947 |
| Avg. Volume (3M) | 2,401,036 |
| Market Cap | 2,935,855,616 |
| Price / Earnings (TTM) | 378.50 |
| Price / Earnings (Forward) | 68.03 |
| Price / Sales | 1.86 |
| Price / Book | 1.71 |
| 52 Weeks Range | |
| Earnings Date | 7 May 2026 |
| Profit Margin | -2.78% |
| Operating Margin (TTM) | 0.48% |
| Diluted EPS (TTM) | -0.090 |
| Quarterly Revenue Growth (YOY) | 10.80% |
| Total Debt/Equity (MRQ) | 33.09% |
| Current Ratio (MRQ) | 1.47 |
| Operating Cash Flow (TTM) | 126.01 M |
| Levered Free Cash Flow (TTM) | 113.77 M |
| Return on Assets (TTM) | -0.33% |
| Return on Equity (TTM) | -2.47% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Bullish |
| Medical Care Facilities (Global) | Bullish | Bullish | |
| Stock | LifeStance Health Group, Inc. | Bullish | Bullish |
AIStockmoo Score
-0.8
| Analyst Consensus | 4.0 |
| Insider Activity | -5.0 |
| Price Volatility | -4.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 4.0 |
| Average | -0.80 |
|
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 8.22% |
| % Held by Institutions | 93.24% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Tpg Gp A, Llc | 31 Dec 2025 | 160,711,618 |
| Summit Partners L P | 31 Dec 2025 | 33,524,715 |
| Silversmith Partners I Gp, Llc | 31 Dec 2025 | 14,324,197 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 12.00 (UBS, 58.52%) | Buy |
| Median | 10.00 (32.10%) | |
| Low | 9.00 (Barclays, 18.89%) | Buy |
| 9.00 (Keybanc, 18.89%) | Buy | |
| Average | 10.20 (34.74%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 7.00 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 06 Mar 2026 | 9.00 (18.89%) | Buy | 6.93 |
| Canaccord Genuity | 26 Feb 2026 | 10.00 (32.10%) | Buy | 6.96 |
| Keybanc | 26 Feb 2026 | 9.00 (18.89%) | Buy | 6.96 |
| UBS | 26 Feb 2026 | 12.00 (58.52%) | Buy | 6.96 |
| BTIG | 02 Feb 2026 | 11.00 (45.31%) | Buy | 7.18 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BESSLER ROBERT | - | 6.94 | -75,000 | -526,959 |
| Aggregate Net Quantity | -75,000 | |||
| Aggregate Net Value ($) | -526,959 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 6.94 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| BESSLER ROBERT | Director | 24 Apr 2026 | Sell (-) | 62,147 | 7.05 | 438,136 |
| BESSLER ROBERT | Director | 23 Apr 2026 | Sell (-) | 7,752 | 6.99 | 54,186 |
| BESSLER ROBERT | Director | 21 Apr 2026 | Sell (-) | 5,101 | 6.79 | 34,636 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |